- $5.75bn
- $7.13bn
- $2.66bn
- 85
- 41
- 86
- 81
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 23.67 | ||
PEG Ratio (f) | 1.11 | ||
EPS Growth (f) | 27.16% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.27 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.19 | ||
EV to EBITDA | 20.67 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.73% | ||
Return on Equity | 1.44% | ||
Operating Margin | 4.97% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 3,308.9 | 2,675.5 | 2,646.9 | 2,704.7 | 2,659.3 | 2,685.67 | 2,768.97 | -5.27% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | +75.32 | +16.68 | +14.5 | +103.24 | +20.09 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Stericycle, Inc. is a business-to-business services company and provider of compliance-based solutions that protect people and brands, promote health and well-being and safeguard the environment. The Company serves customers in North America and Europe with solutions for regulated waste and compliance services (RWCS) and secure information destruction (SID). Its RWCS include biohazardous waste disposal, compliance solutions (including Steri-Safe Compliance Solutions), specialty services and medical supply store. Its specialty services include MedDrop Medication Collection Kiosks, Safe Community Solutions, SafeDrop Sharps Mailback Solutions, and Airport and Maritime Waste Services. The Company's SID services include SID and compliance solutions (including document, hard drive, and specialty destruction services) under the Shred-it brand name, which includes regular scheduled services (and processing onsite and offsite) and one-time services (including select, priority and express).
Directors
- Robert Murley NEC (71)
- Cindy Miller PRE (59)
- Janet Zelenka CFO (62)
- Joseph Reuter CHO (59)
- Michael Weisman EVP (62)
- Kurt Rogers EVP (49)
- Dominic Culotta EVP (57)
- Daniel Ginnetti EVP (52)
- Richard Moore EVP (59)
- S. Cory White EVP (48)
- Brian Anderson IND (70)
- Lynn Bleil IND (57)
- Thomas Chen IND (71)
- J. Joel Hackney IND (51)
- Veronica Hagen IND (75)
- Stephen Hooley IND (58)
- James Martell IND (66)
- Kay Priestly IND (65)
- James Welch IND (66)
- Michael Zafirovski IND (67)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- March 21st, 1989
- Public Since
- August 1st, 1996
- No. of Shareholders
- 78
- No. of Employees
- 13,500
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 92,836,450

- Address
- 2355 Waukegan Road, BANNOCKBURN, 60015
- Web
- https://www.stericycle.com
- Phone
- +1 8473675910
- Auditors
- Ernst & Young LLP
Upcoming Events for SRCL
Q1 2025 Stericycle Inc Earnings Release
Similar to SRCL
Acacia Research
NASDAQ Global Select Market
Afya
NASDAQ Global Select Market
AvidXchange Holdings
NASDAQ Global Select Market
Barrett Business Services
NASDAQ Global Select Market
Casella Waste Systems
NASDAQ Global Select Market
FAQ
As of Today at 22:28 UTC, shares in Stericycle are trading at $61.98. This share price information is delayed by 15 minutes.
Shares in Stericycle last closed at $61.98 and the price had moved by +49.21% over the past 365 days. In terms of relative price strength the Stericycle share price has outperformed the S&P500 Index by +13.51% over the past year.
The overall consensus recommendation for Stericycle is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreStericycle does not currently pay a dividend.
Stericycle does not currently pay a dividend.
Stericycle does not currently pay a dividend.
To buy shares in Stericycle you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $61.98, shares in Stericycle had a market capitalisation of $5.75bn.
Here are the trading details for Stericycle:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: SRCL
Based on an overall assessment of its quality, value and momentum Stericycle is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Stericycle is $61.77. That is 0.34% below the last closing price of $61.98.
Analysts covering Stericycle currently have a consensus Earnings Per Share (EPS) forecast of $2.24 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stericycle. Over the past six months, its share price has outperformed the S&P500 Index by +21.37%.
As of the last closing price of $61.98, shares in Stericycle were trading +12.8% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Stericycle PE ratio based on its reported earnings over the past 12 months is 23.67. The shares last closed at $61.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Stericycle's management team is headed by:
- Robert Murley - NEC
- Cindy Miller - PRE
- Janet Zelenka - CFO
- Joseph Reuter - CHO
- Michael Weisman - EVP
- Kurt Rogers - EVP
- Dominic Culotta - EVP
- Daniel Ginnetti - EVP
- Richard Moore - EVP
- S. Cory White - EVP
- Brian Anderson - IND
- Lynn Bleil - IND
- Thomas Chen - IND
- J. Joel Hackney - IND
- Veronica Hagen - IND
- Stephen Hooley - IND
- James Martell - IND
- Kay Priestly - IND
- James Welch - IND
- Michael Zafirovski - IND